NetScientific PLC AGM Statement (7804Q)
22 Junho 2015 - 3:00AM
UK Regulatory
TIDMNSCI
RNS Number : 7804Q
NetScientific PLC
22 June 2015
NetScientific plc
Annual General Meeting
London, UK - 22 June 2015 - NetScientific plc ("NetScientific"
or "the Group", AIM: NSCI), the biomedical and healthcare
technology group, is holding its Annual General Meeting (AGM) today
at 11am. Ahead of this meeting Chairman, Sir Richard Sykes, will
make the following comments:
"2015 has been transformational for the Group's evolution.
Notably, our Board review of the business strategy has led to a
revitalised focus on funding, development and management of early
and mid-stage healthcare technology companies, sourced from USA and
UK strategic partnerships. We are concentrating on three core areas
- proven technology in digital health, diagnostics and
therapeutics. These sectors represent highly attractive growth
markets where breakthrough technology solutions are in high
demand.
"The appointment of François Martelet as CEO in June was well
timed for him to lead on the new strategy, bringing over 20 years'
of biopharma experience and knowledge of commercialisation with him
to further strengthen the team. François will be presenting at the
AGM to highlight his next steps in the management of the Group
including his plans to undergo an in-depth, systematic portfolio
review in the three healthcare segments. He will stress his
intention to accelerate growth in NetScientific's lead portfolio
companies - Wanda, Vortex, Glucosense, Glycotest and Proaxsis and
divest interests in non-core assets. A fuller update will follow
with the interim results in September.
"Today Nicholas Heckford, Executive Director - Commercial and
Legal, has announced his retirement and departure from the Board at
the end of September. Most of his responsibilities will be taken up
by the Company Secretary, Ernest Schneider. Nicholas has been with
the Group since inception and his contribution has been significant
and much appreciated. We wish him all the best in his
retirement."
François Martelet's presentation will be available on
Netscientific's website after the meeting.
-Ends-
About NetScientific
NetScientific is a biomedical and healthcare technology group
that funds and develops technologies that offer transformative
benefits to people's lives and society through improved diagnosis,
prognosis and treatment. For more information, please visit the
website at www.netscientific.net
Contact Details
NetScientific
Peter Thoms, CFO
Tel: +44 (0)77 2055 5752
Investec
Gary Clarence / Daniel Adams
Tel: +44 (0)20 7597 4000
Instinctif Partners
Melanie Toyne-Sewell / Jayne Crook
Tel: +44 (0)20 7457 2020 Email: netscientific@instinctif.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMFBMTTMBATTBA
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024